Myxoid spindle cell sarcoma with ETV6-NTRK3 fusion

Area of Science:

• Oncology
• Molecular Pathology
• Genetics

Background:

• Myxoid spindle cell sarcoma presents diagnostic challenges due to a lack of specific immunohistochemistry markers.
• Genetic analysis reveals complex karyotypic alterations but no characteristic molecular abnormalities for this sarcoma type.
• NTRK alterations are infrequent but clinically significant, offering therapeutic targets with NTRK inhibitors.

Observation:

• This case involves an adult patient diagnosed with unclassified myxoid spindle cell sarcoma.
• The sarcoma displayed an ETV6/NTRK3 fusion gene.

Findings:

• The identified ETV6/NTRK3 fusion gene is a molecular hallmark typically associated with infantile fibrosarcoma.
• This finding represents a rare genetic event in adult myxoid spindle cell sarcoma.

Implications:

• The presence of the ETV6/NTRK3 fusion gene suggests potential therapeutic strategies targeting NTRK.
• This case expands the understanding of molecular alterations in rare sarcomas.
• Highlights the importance of molecular diagnostics in sarcoma classification and treatment selection.